#BCI technology is advancing in impactful ways thanks to the collaborative spirit of the FDA and the diverse stakeholders within the BCI field. In our latest blog posts, read more about the Implantable Brain Computer Interface Collaborative Community (iBCI-CC) and the role of the FDA in ensuring more rapid development and patient access to safe, effective, high-quality brain computer interface technology. iBCI-CC: Empowering Through Collaboration 👇 https://lnkd.in/gAcx5JPB The Role of FDA in the BCI Journey👇 https://lnkd.in/gpq4XgBu
Paradromics Inc.
Biotechnology Research
Austin, Texas 16,735 followers
Building a high data-rate brain computer interface (BCI) to provide technology solutions to unmet medical needs.
About us
CONNECTING THE HUMAN BRAIN What if we could restore or enhance function using the power of AI and advanced technology? Our direct data interface enables this connection. MISSION We are building a high data-rate brain computer interface (BCI) to provide technology solutions for people with neurological and brain-related conditions. Our first clinical application will help severely motor-impaired people communicate, enabling social connection and restoring independence. ABOUT Paradromics was founded in 2015 by a team of engineers and neuroscientists, received early support from both NIH and DARPA, and is currently backed by venture capital.
- Website
-
www.paradromics.com
External link for Paradromics Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Austin, Texas
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Neural Interfaces, Brain Computer Interface, Assistive Communication Devices, Direct Data Interface, DDI, BCI, and Neuroscience
Products
Locations
-
Primary
Get directions
4030 W Braker Ln
Austin, Texas 78759, US
Employees at Paradromics Inc.
-
Adam Weiss
Staff Research Engineer @ Paradromics
-
Daren Martin
WSJ, USA Today & Amazon Bestselling Author | Motivational Keynote Speaker | Executive Coach | C-Suite Advisor | Global Company Culture Association…
-
Ken Walker
Director, Medical Services
-
Matt Marino
Vice President Finance at Paradromics Inc
Updates
-
We are looking forward to Vikash Gilja participating in an informative panel this Thursday at IEEE Engineering Medicine and Biology Society 2024!
#BCI - State of the Art, Art of the Future. We're back for another year of BCI vision, mission, and reality. Come to #EMBC2024 on July 18 to hear from execs from the companies leading the BCI field. https://lnkd.in/gxjZg4Du
-
-
Thanks Ashley Capoot! Great article featuring Paradromics on CNBC's Healthy Returns. https://lnkd.in/gCvt4WCX
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
cnbc.com
-
🚨 Don't miss the season 3 premiere of Neurotech Pub! Join our CEO, Matt Angle, and leading experts Jacob Robinson from Motif Neurotech, Grayson Z. from Resonant Link, and Alexander Yeh from Neuspera Medical Inc. as they discuss the groundbreaking developments in wireless power technologies for implantable devices. From high data rate brain-computer interfaces to life-changing mental health treatments, this episode is packed with insights on the future of neurotech. 🎙️🧠 Listen to the full episode: https://lnkd.in/gdDjG_6e #NeurotechPub #BCI
-
Great recap on the Neurotech industry in June. Thanks Naveen Rao! Be sure to subscribe to Neurotech Futures for an in-depth exploration of the emerging field of neurotechnology and its impact on brain health, markets, and ethics. https://lnkd.in/g9cjYvQV
Neurotech Notables #11: June 2024
neurotechnology.substack.com
-
📣 Exciting news! Paradromics has been accepted into the U.S. FDA’s newest accelerator program (TAP) and we have received our second Breakthrough Device Designation! These programs offer an expedited review process for transformative medical devices (like #BCIs 🧠). Matthew Willsey, MD, PhD, a leading neurosurgeon at the University of Michigan Medical School stated, “I’m excited to see BCI technologies, such as the Connexus® device, entering the clinical phase. This is one step closer to restoring movement to people with paralysis, or speech to those who have lost this function.” In preparation for our clinical trials in 2025, we have also launched the Paradromics Community, where patients, caregivers, and allies can stay up-to-date about current and future applications of Paradromics’ core technology. Read the full press release: https://lnkd.in/gWyjBpM4
Paradromics accepted to FDA regulatory accelerator program and announces new patient registry
prnewswire.com
-
“But, this isn’t just about profit – it’s also about this tech’s potential to change our daily lives, revolutionize the medical field, and even impact the course of human evolution.” Great informative video on the #neurotech industry and the current competitive landscape, Morning Brew! Shoutouts to Jacob Robinson, Founder & CEO Motif Neurotech, Ian Burkhart, and Harrison Canning 🧠, neurotechnologist at the The BCI Guys! It’s an exciting time in #BCI. Watch the full video: https://lnkd.in/gcv7Gazc
Companies Are Racing To Put A Chip In Your Brain
https://www.youtube.com/
-
“I think there could be a different conversation 20 years from now, and some of those devices could also have consumer applications. But in the meantime, we’re really focused on building safe, reliable, robust devices for people with physical and mental conditions.” - Founder and CEO of Paradromics, Matt Angle Read more: https://lnkd.in/gAiQQviH
A Neuralink competitor will test its brain chip in humans next year
qz.com
-
The incredible research initiated by the BrainGate Team 20 years ago has launched an exciting field of brain computer interfaces that we are proud to be a part of. We look forward to the many clinical advancements that this research continues to foster.
20 years ago (June 22nd 2004, to be precise), an extraordinary 24-year-old, unable to move his hands due to cervical spinal cord injury, volunteered to have a tiny sensor placed into his brain so that he could control a computer cursor, his room lights, and a robot arm just by thinking about it. https://lnkd.in/ePde7BiF
BrainGate Team (@BrainGateTeam) on X
x.com
-
Today is Global ALS Awareness Day, a day dedicated to recognizing the people affected by #ALS around the world. With more than 200,000 people impacted, we are working diligently towards our first clinical application of our Connexus® Direct Data Interface, where we will help severely motor-impaired people communicate, enabling social connection and restoring independence. “Until there is a cure, technology is the cure.” - Steve Gleason, on living with ALS and utilizing a speech generating device. #ALSMNDWithoutBorders #alsawareness
-